Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RVMD
#514
Revolution Medicines, Inc. Common Stock
102.020
0
+0.79%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.79%
Variazione Mensile
+3.01%
Variazione di 6 mesi
+84.15%
Variazione Annuale
+84.15%
Chiusura Precedente
101.220
0
Open
102.020
0
Bid
Ask
Low
102.020
0
High
102.020
0
Volume
349
Mercati
Mercato Azionario Statunitense
Salute
RVMD
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
168.22 M
185.91 M
186.27 M
186.93 M
193.32 M
198.17 M
—
Valuation ratios
Enterprise value
7.43 B
7.59 B
6.25 B
6.47 B
8.81 B
15.4 B
36.94 B
Price to earnings ratio
-12.32
-12.22
-8.82
-8.14
-8.98
-13.39
-39.32
Price to sales ratio
6 915.56
—
5 246.72
3 688.56
3 511.79
—
—
Price to cash flow ratio
12.6
13.16
10.35
9.64
11.31
16.87
48.17
Price to book ratio
0.99
3.24
0.81
0.84
1.09
9.28
12.02
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.09
-0.08
-0.09
-0.1
-0.14
-0.15
-0.48
Return on equity %
-0.1
-0.09
-0.1
-0.13
-0.19
-0.22
-0.65
Return on invested capital %
-286.23
-309.69
—
—
—
96.88
—
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-18.99 K
-43.4 K
-50.12 K
-43.31 K
-155.81 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
-16.83 K
-40.62 K
-48.52 K
-43.7 K
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.24
14.2
13.46
11.79
8.05
7.14
40.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.78
-0.82
-1.03
-1.18
-1.1
-1.44
-4.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.29
13.65
11.18
11.33
10.21
10.65
43.37
Net current asset value per share
9.46
13.88
11.35
11.54
10.45
10.91
44.25
Tangible book value per share
8.96
13.08
10.67
9.52
8.07
8.21
36.46
Working capital per share
8.8
12.9
10.5
10.56
9.15
9.39
39.6
Book value per share
9.39
13.5
11.05
9.89
8.44
8.58
37.96
Notizie
UBS avvia copertura su Revolution con rating buy sul potenziale degli inibitori RAS
UBS assumes coverage on Revolution stock with buy rating on RAS inhibitor potential
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Piper Sandler alza il target su Revolution Medicines per fiducia nel farmaco
Piper Sandler raises Revolution stock price target on drug confidence
Needham riduce il target di prezzo di Revolution a 145$ per costi più elevati
Needham lowers Revolution stock price target to $145 on higher costs
Wells Fargo alza il target su Revolution per i progressi degli studi
Wells Fargo raises Revolution stock price target on trial progress
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript
Revolution Medicines in spotlight as earnings loom after M&A chatter
BB Biotech FY 2025: utili +660%, outlook 2026 cauto